Fundraising Fox

Repligen

NASDAQ: RGEN

Waltham, US · Delaware corporation

Healthtech

Founders & leadership

TJ
Tony J. HuntExecutive
JK
Jon K. SnodgresExecutive
HB
Howard BenjaminNamed on SEC filing
AH
ANTHONY HUNTNamed on SEC filing
WC
WALTER C. HERLIHYNamed on SEC filing
AL
ALFRED L. GOLDBERGNamed on SEC filing
JG
JOHN G. COXNamed on SEC filing
JR
JAMES R. RUSCHENamed on SEC filing
TF
THOMAS F. RYAN , JR.Named on SEC filing
GL
GLENN L. COOPERNamed on SEC filing
MA
MICHAEL A. GRIFFITHNamed on SEC filing
DP
DANIEL P. WITTNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$290.6M disclosed across 3 rounds · 2014–2019

▶$48MraisedJun 2019 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John G. CoxDirector
  • Glenn P. MuirDirector
  • Tony J. HuntExecutive Officer, Director
  • Jon K. SnodgresExecutive Officer
  • Ralf J. KuriyelExecutive Officer
  • Thomas F. Ryan, Jr.Director
  • Karen A. DawesDirector
  • Nicolas M. BarthelemyDirector
  • Glenn L. CooperDirector
Offering amount
$48M
Amount sold
$48M
First sale
May 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$238.6MraisedAug 2017 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Howard BenjaminExecutive Officer
  • Glenn L. CooperDirector
  • Thomas F. Ryan, Jr.Director
  • Tony J. HuntExecutive Officer, Director
  • Karen A. DawesDirector
  • John G. CoxDirector
  • Nicolas M. BarthelemyDirector
  • Jon K. SnodgresExecutive Officer
  • Glenn P. MuirDirector
Offering amount
$238.6M
Amount sold
$238.6M
First sale
Aug 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedJun 2014 · 1 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • ANTHONY HUNTExecutive Officer
  • WALTER C. HERLIHYExecutive Officer, Director
  • ALFRED L. GOLDBERGDirector
  • JOHN G. COXDirector
  • JAMES R. RUSCHEExecutive Officer
  • THOMAS F. RYAN , JR.Director
  • GLENN L. COOPERDirector
  • MICHAEL A. GRIFFITHDirector
  • DANIEL P. WITTExecutive Officer
  • HOWARD BENJAMINExecutive Officer
  • NICOLAS BARTHELEMYDirector
  • KAREN A. DAWESDirector
Offering amount
$4M
Amount sold
$4M
First sale
Jun 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Acquisitions · 1

Early investors' stakes continue via these deals
Tantti

Chromatography innovator acquired by Repligen.

Frequently asked questions

How much funding has Repligen raised?
Repligen has disclosed $290.6M raised across 3 rounds.
Where is Repligen headquartered?
Repligen is headquartered in Waltham, US.